Europe — EMA

Orlistat Polpharma

Orlistat, the active ingredient in Orlistat Polpharma, is a lipase inhibitor presented as a unknown/unknown for oral use. It treats obesity by reducing dietary fat absorption in adults.

Orlistat

Request sourcing

Pack/s

What is Orlistat?

Orlistat, the active ingredient in Orlistat Polpharma, is a lipase inhibitor presented as a unknown/unknown for oral use. It treats obesity by reducing dietary fat absorption in adults. GNH USA supplies Orlistat Polpharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orlistat Polpharma is marketed in the European Union and conforms to EU pharmaceutical standards.

What is Orlistat used for?

Orlistat Polpharma is a lipase inhibitor that acts on the gastrointestinal tract to aid - Overweight : It ... - ... … - … … ... - … … … ... - … … ... ...

What are the side effects of Orlistat?

Common

What precautions apply to Orlistat?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →